SCT Past Presidents


Sumithra Mandrekar
Presidential Term 2018-2019
Coming soon...
Theodore Karrison
Presidential Term 2017-2018
Fellow Induction: 2011
Ted has been a Research Associate at the University of Chicago, actively collaborating on clinical trials since 1975. He has had a direct impact on the design and analysis of clinical trials across a broad range of diseases and therapies, most recently in cancer. Ted has published several statistical methods papers, particularly in the area of survival analysis and in the design of phase II clinical trials with a continuous endpoint. He has been an active member of SCT since 1980. Ted chaired the Student Scholarship Committee, was elected to the Board of Directors, chaired the Program Committee for the 2004 Annual Meeting, and has been serving as an Associate Editor of Controlled Clinical Trials/Clinical Trials since 1999.
Domenic J. Reda
Presidential Term 2016-2017
Fellow Induction: 2012
For contributions to the advancement of clinical trials in trial coordination, conduct and leadership; education; and service to the Society.
Wendy R. Parulekar
Presidential Term 2015-2016
Fellow Induction: 2011
Wendy has been a Physician Coordinator at the NCIC Clinical Trials Group since 1999. As Co-Principal Investigator on 31 trials of genitourinary, gastrointestinal, head and neck, and breast cancers designed to assess practice-changing policy issues, Wendy has direct responsibility for oversight of study conduct including protocol development, data collection and review, and medical input into the design and execution of the analysis. Wendy created and directs the NCIC New Investigator Clinical Trials Workshop that has received outstanding evaluations. Wendy is active in SCT serving on committees, was elected to the Board of Directors, and chaired the Program Committee for the 2009 Annual Meeting.
KyungMann Kim
Presidential Term 2014-2015
Fellow Induction: 2012
For contributions to the advancement of clinical trials through methodologic development; trial coordination, conduct and leadership; education; and service to the Society.
Daniel J. Sargent
Presidential Term 2013-2014
Fellow Induction: 2012
For methodologic research related to clinical trials; leadership in the coordination of major cancer clinical trial programs; and service to the Society.
Anne S. Lindblad
Presidential Term 2012-2013
Fellow Induction: 2015
For important contributions and leadership in the design, conduct and publication of research in ophthalmology, transplantation, neurology, dentistry, nephrology, swallowing, and oncology. For her work and publications exploring barriers to clinical trial participation and techniques to increase efficiency and quality in trial conduct. For her commitment to teaching clinical trial methodology to non statisticians, her service on data and safety monitoring boards and advisory committees, and her long and distinguished service to the Society.
Rick Chappell
Presidential Term 2011-2012
Fellow Induction: 2014
For important contributions to the statistical methodology for the design and analysis of clinical trials, particularly in cancer and aging; for leadership in clinical trial coordination and conduct at the University of Wisconsin Comprehensive Cancer Center; for national leadership on numerous DSMBs and advisory committees, including NIH and FDA; and for distinguished service to the Society.
Robert P. Byington
Presidential Term 2010-2011
Fellow Induction: 2013
For his contributions to the advancement of clinical trials in methodologic development; trial coordination, conduct and leadership; education; and service to the Society.
Colin B. Begg
Presidential Term 2009-2010
Fellow Induction: 2012
For leadership in the design and conduct of clinical trials, particularly in oncology; for development of statistical methods for applications to clinical trials; and for service to the Society.
Kay Dickersin
Presidential Term 2008-2009
Fellow Induction: 2011
Kay has been Director, Center for Clinical Trials, Johns Hopkins Bloomberg School of Public Health since 2005. Kay has been a leader in the fight to make registration of clinical trials a requirement worldwide. Kays publications on the existence and extent of publication bias are classics. Kay has been a member of many national and international advisory panels dealing with clinical trials, meta-analysis, and treatment guidelines. Kay serves as the overall US Center Director of the Cochrane Collaboration and is an active member of the National Breast Cancer Coalition. Kay has been an active member of SCT serving on numerous committees; she was elected to the Board of Directors, was elected to serve as President 2008-2009, and currently chairs the Publication Committee.
Eleanor McFadden
Presidential Term 2007-2008
Fellow Induction: 2012
For leadership in the design and coordination of clinical trials and groups, principally in oncology ; for contribution to the methodology of clinical trials, particularly data management; and for substantial service to the Society.